BlackRock Emerging Mkt L/S Eq Investor C
BLACKROCK MUNICIPAL BOND FUND, INC100 BELLEVUE PARKWAYWILMINGTON NJ 19809
Map
Phone: 800-441-7762
| Category: | Long/Short Equity | | Fund Family: | BlackRock | | Net Assets: | 562.99M | | Year-to-Date Return: | -1.70% | | Yield: | 0.00% | | Morningstar Rating: | N/A | | Fund Inception Date: | Oct 5, 2011 |
|
Jeff Shen
Lead Manager since Oct 5, 2011 | | | Jeff Shen, PhD, Managing Director, is the Head of Asia Pacific and Emerging Market Equity within BlackRock's Scientific Active Equity (SAE) Group. He is a member of the Global Operating Committee, Human Capital Committee and Asia Pacific Executive Committee.
Dr. Shen's service with the firm dates back to 2004, including his years with Barclays Global Investors (BGI), which merged with BlackRock in 2009. At BGI, he was the Head of Asia and Emerging Market equity investment. Prior to joining BGI, he was the global head of asset allocation research and macro absolute return investment at JP Morgan Asset Management. Dr. Shen began his career in 1997 and worked in fund of hedge funds, risk management research and macro investment functions for JP Morgan in New York and London. In addition, he is an adjunct professor at NYU and UC Berkeley teaching MBA/MFE classes on international investment.
Dr. Shen earned a BA degree in economics from Hobart College, an MAdegree in economics from the University of Massachusetts at Amherst, and a PhD degree in finance from New York University. |
| Min Initial Investment: | 1,000 | | Min Initial Investment, IRA: | 1,000 | | Min Initial Investment, AIP: | 50 | | Min Subsequent Investment: | 50 | | Min Subsequent Investment, IRA: | N/A | | Min Subsequent Investment, AIP: | 50 |
|
| |
| The investment seeks total return over the long term.
Under normal conditions, the fund invests at least 80% of its total assets in global equity instruments and related derivative instruments issued by, or tied economically to, companies in emerging markets. It may invest in securities of issuers of any market capitalization and in securities denominated in either U.S. dollars or foreign currencies. The fund pursues its investment objective by taking both long and short positions in a variety of global equity instruments. It may invest up to 20% of its assets in equity instruments issued by or based on companies located outside of emerging markets. |
| Last Dividend
:
| 0.00 | | Last Cap Gain
(Dec 25, 2012)
:
| 0.00 | | Annual Holdings Turnover
(May 15, 2013)
:
| N/A | | Average for Category: | 396.78% |
|
| Expense | BLSCX | Category Avg |
|---|
| Annual Report Expense Ratio (net): | 2.75% | 1.97% | | Prospectus Net Expense Ratio: | 2.75% | N/A | | Prospectus Gross Expense Ratio: | 3.00% | N/A | | Max 12b1 Fee: | 1.00% | N/A | | Max Front End Sales Load: | N/A | 5.33% | | Max Deferred Sales Load:
| 1.00% | 1.24% | | 3 Yr Expense Projection*: | 904 | 969 | | 5 Yr Expense Projection*: | 1,555 | 1,554 | | 10 Yr Expense Projection*: | 3,300 | 3,158 |
|
|
0.01(0.09%) May 21